• Home
  • About Us
  • Business Segments
    • HealthID
      • iGlucose
      • Easy Check
      • Glucose Sensing Microchip
      • Virus Detection System
    • ID Security
      • Health Link
      • National Credit Report
  • Investors & Media
    • Press Releases & Media
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Investor FAQs
    • Contact Us
  • Contact Us

HealthID

PositiveID's HealthID division develops innovative health solutions for consumers, businesses and animals. From blood glucose monitoring and other diabetes management products to rapid virus detection, PositiveID is charting new ground with its exciting array of new medical technologies.

 

VeriMed

PositiveID's HealthID business is based primarily on the company's history in RFID, or radio-frequency identification. There is no better example of this than the legacy VeriMed™ system. A first-of-its-kind system for patient identification, VeriMed consists of an FDA-cleared, RFID human-implantable microchip that links to a personal health record. This allows doctors immediate access to even non-responsive patients, and can help hospital personnel treat a non-communicative patient quickly and effectively in the event of an emergency. The microchip does not contain any medical records; rather, it contains a 16-digit number that, when scanned with a proprietary handheld reader, connects to a secure, online database. The database houses the patient’s identification information and personal health records, which can only be accessed by medical professionals with the proper login and password information. Although currently PositiveID does not actively market the VeriMed system, it continues to support existing patients and healthcare facilities.

 

Diabetes Management

 

In February 2010, PositiveID acquired the intellectual property rights and assets of Easy Check Medical Diagnostics, LLC, to expand its portfolio of non-invasive glucose-level testing products and diabetes management tools under development. With the Easy Check acquisition came two development products: the Easy Check breath glucose test , a non-invasive glucose detection system that measures acetone levels in a patient’s exhaled breath; and the iGlucose system, which uses wireless SMS messaging to automatically communicate a diabetic’s glucose readings to the iGlucose online database.

 

Bio-sensors

 

In addition to our intellectual property surrounding the implantable RFID microchip for patient identification, we own patents related to an embedded bio-sensor system. One potential application of this bio-sensor system is an implantable, bio-sensing RFID microchip to measure glucose levels in the body in real time.

 

Pandemic Virus Detection

 

PositiveID is also developing a rapid virus detection system for the H1N1 virus, other forms of influenza and other pandemic illnesses. Importantly, PositiveID believes the influenza triage diagnostic system will be scalable and will be able to be rapidly adapted to identify new strains of influenza and other viruses as they evolve, giving the virus triage detection system value for future testing applications in healthcare.

 

 
 

 

 

Home | About Us | Business Segments | Investors & Media | Contact Us